| Term 
 | Definition 
 
        | 9 -> (7+TF) -> 9a X -> (9a) -> Xa
 proThrombin -> (Xa) -> Thrombin
 Fibrinogen -> (thrombin) -> Fibrin clot
 
 *fibrin binds platelets and crosslinks them
 *cascade is catalytic/amplifiable, NOT stoicheometric (1:1)
 *normal aPTT time = 30 sec
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decreased cAMP thrombin
 ADP
 TXA2
 5HT/serotonin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Half-lives of clotting factors |  | Definition 
 
        | Factor VII	5 hours Protein C	6 hours
 Factor IX	15 hours
 Factor X	1 day
 Prothrombin	2-3 days
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - antithrombin MOA - huge sugar chain that inhibits thrombin by binding it to antithrombin. also binds factor Xa to antithrombin. it is catalytic bc once it facilitates binding it releases itself and can act again (so it's action is antithrombin dependent).
 Increases: LPL (which cleaves TGs)
 Decreases: thrombin, fibrin
 AE - thrombocytopenia, thrombosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - factor Xa inhibitor (LMWH) MOA - smaller sugar chain that inhibits factor Xa by binding it to antithrombin. it is also catalytic and antithrombin dependent.
 Decreases: factor Xa, thrombin, fibrin
 AE - thrombocytopenia, thrombosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - vitamin K reductase inhibitor MOA - keeps vitamin K in an oxidized state so it can't catalyze the carboxylation of clotting factors which lowers their affinity to Ca+
 Decreases: various clotting factors
 AE - bleeding, necrosis, pregnancy-X
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - adenosine receptor inhibitor MOA - prodrug that prevents ADP from binding to platelets which in turn increases cAMP
 where: platelets
 Increases: cAMP
 Decreases: ADP
 AE - thrombocytopenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - PDE(3) inhibitor MOA - inhibits PDE(3) which converts cAMP
 where: platelets
 Increases: cAMP
 AE - headache
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class - integrin inhibitor MOA - blocks integrin which is a receptor for fibrinogren on platelets
 where: platelets
 Decreases: binding/crosslinking
 AE - hypersensitivity (mouse part)
 |  | 
        |  |